CTRI Number |
CTRI/2013/12/004258 [Registered on: 30/12/2013] Trial Registered Retrospectively |
Last Modified On: |
03/12/2018 |
Post Graduate Thesis |
No |
Type of Trial |
Interventional |
Type of Study
|
Unani |
Study Design |
Single Arm Study |
Public Title of Study
|
To evaluate the Safety and efficacy of two Unani formulations in the treatment of overactive bladder. |
Scientific Title of Study
|
Validation of Unani Pharmacopoeial formulations in Zof-e-Masana (Overactive Bladder) |
Trial Acronym |
|
Secondary IDs if Any
|
Secondary ID |
Identifier |
NIL |
NIL |
|
Details of Principal Investigator or overall Trial Coordinator (multi-center study)
|
Name |
DR ABDUL HANNAN |
Designation |
Joint Director (Unani) |
Affiliation |
Central Council for Research in Unani Medicine (CCRUM), |
Address |
Central Council for Research in Unani Medicine (CCRUM), Jawahar Lal Nehru Bhartiya Chikitsa Evam Homoeopathy Anusandhan Bhawan, 61-65, Institutional Area, Opp. D Block, Janakpuri, New Delhi Central Council for Research in Unani Medicine (CCRUM), Jawahar Lal Nehru Bhartiya Chikitsa Evam Homoeopathy Anusandhan Bhawan, 61-65, Institutional Area, Opp. D Block, Janakpuri, New Delhi New Delhi DELHI 110058. India |
Phone |
011-28521981 |
Fax |
011-28522965 |
Email |
ccrum605@gmail.com |
|
Details of Contact Person Scientific Query
|
Name |
DR ABDUL HANNAN |
Designation |
Joint Director (Unani) |
Affiliation |
Central Council for Research in Unani Medicine (CCRUM), |
Address |
Central Council for Research in Unani Medicine (CCRUM), Jawahar Lal Nehru Bhartiya Chikitsa Evam Homoeopathy Anusandhan Bhawan, 61-65, Institutional Area, Opp. D Block, Janakpuri, New Delhi Central Council for Research in Unani Medicine (CCRUM), Jawahar Lal Nehru Bhartiya Chikitsa Evam Homoeopathy Anusandhan Bhawan, 61-65, Institutional Area, Opp. D Block, Janakpuri, New Delhi New Delhi DELHI 110058. India |
Phone |
011-28521981 |
Fax |
011-28522965 |
Email |
ccrum605@gmail.com |
|
Details of Contact Person Public Query
|
Name |
DR ABDUL HANNAN |
Designation |
Joint Director (Unani) |
Affiliation |
Central Council for Research in Unani Medicine (CCRUM), |
Address |
Central Council for Research in Unani Medicine (CCRUM), Jawahar Lal Nehru Bhartiya Chikitsa Evam Homoeopathy Anusandhan Bhawan, 61-65, Institutional Area, Opp. D Block, Janakpuri, New Delhi Central Council for Research in Unani Medicine (CCRUM), Jawahar Lal Nehru Bhartiya Chikitsa Evam Homoeopathy Anusandhan Bhawan, 61-65, Institutional Area, Opp. D Block, Janakpuri, New Delhi New Delhi DELHI 110058. India |
Phone |
011-28521981 |
Fax |
011-28522965 |
Email |
ccrum605@gmail.com |
|
Source of Monetary or Material Support
|
Infrastructural support :
1 Central Research Institute of Unani Medicine (CRIUM), Hyderabad
2. Central Research Institute of Unani Medicine(CRIUM), Lucknow
3. Regional Research Institute of Unani Medicine(RRIUM), Srinagar
Monetary Support : Central Council for Research in Unani Medicine (CCRUM), New Delhi
|
|
Primary Sponsor
|
Name |
Central Council for Research in Unani Medicine CCRUM New Delhi |
Address |
Central Council for Research in Unani Medicine (CCRUM), Jawahar Lal Nehru Bhartiya Chikitsa Evam Homoeopathy Anusandhan Bhawan, 61-65, Institutional Area, Opp. D Block, Janakpuri, New Delhi-110058. |
Type of Sponsor |
Research institution |
|
Details of Secondary Sponsor
|
|
Countries of Recruitment
|
India |
Sites of Study
|
No of Sites = 3 |
Name of Principal
Investigator |
Name of Site |
Site Address |
Phone/Fax/Email |
DR MOHD ISMAIL |
Central Research Institute of Unani Medicine (CRIUM), Hyderabad |
AG Colony road, Erragadda, Hyderabad- 500038 Hyderabad ANDHRA PRADESH |
040-23810246 040-23811495 mohammedismail5654@yahoo.in |
DR M A KHAN |
REGIONAL RESEARCH INSTITUTE OF UNANI MEDICINE |
Central Research Institute of Unani Medicine (CRIUM), Lucknow Lucknow UTTAR PRADESH |
0522-2361720 0522-2732088 khanmaqboolahmed@gmail.com |
DR SHAISTA UROOJ |
REGIONAL RESEARCH INSTITUTE OF UNANI MEDICINE |
University of Kashmir, Srinagar-190006 Srinagar JAMMU & KASHMIR |
0194-2421604 0194-2421604 rrium.srinagar@gmail.com |
|
Details of Ethics Committee
|
No of Ethics Committees= 3 |
Name of Committee |
Approval Status |
CRIUM HYDERABAD INSTITUTIONAL ETHICS COMMITTE |
Approved |
CRIUM LUCKNOW INSTITUTIONAL ETHICS COMMITTEE |
Approved |
RRIUM SRINAGAR INSTITUTIONAL ETHICS COMMITTEE |
Approved |
|
Regulatory Clearance Status from DCGI
|
|
Health Condition / Problems Studied
Modification(s)
|
Health Type |
Condition |
Patients |
(1) ICD-10 Condition: N329||Bladder disorder, unspecified, Zof-e-Masana (Overactive Bladder), |
|
Intervention / Comparator Agent
|
Type |
Name |
Details |
Intervention |
1. Majoon Flasfa
2. Majoon Masik ul baul
|
1. Majoon Filasfa, 7 gm orally in the morning
2. Majoon Masikul Baul 7 gm orally in the morning.
Duration of therapy is 12 weeks
All the medicines will be give to the same patient |
Comparator Agent |
NIL |
NA |
|
Inclusion Criteria
|
Age From |
18.00 Year(s) |
Age To |
55.00 Year(s) |
Gender |
Both |
Details |
1. Age- more than 18 yrs and upto 65 yrs
2. Gender- both
3. History of the following symptoms for more than six months
• Urgency of urine
• Incontinence
• Dysuria
|
|
ExclusionCriteria |
Details |
Patients with Bladder calculus
2. Patients withUrinary tract infections
3. Patients with Benign Prostrate Hypertrophy
4. Patients with Uterine prolapse
5. Patients with Rectocele/cystocele
6. Patients with Cystitis
7. Patients with Diabetes Mellitus
8. Patients with Hypertension
9. Pregnant and lactating females
10. Neoplasm
11. Patients with Hepatic/Cardiac diseases
12. Medications (anticholinergic, antidepressant, psychotropic, or alpha-blocker)
13. Patients with History of any Spinal cord injury |
|
Method of Generating Random Sequence
|
Not Applicable |
Method of Concealment
|
Not Applicable |
Blinding/Masking
|
Not Applicable |
Primary Outcome
|
Outcome |
TimePoints |
Improvements in signs and symptoms of Hypertension
|
12WEEKS |
|
Secondary Outcome
|
Outcome |
TimePoints |
Hematological and biochemical assessments for safety
|
12 WEEKS |
|
Target Sample Size
|
Total Sample Size="300" Sample Size from India="300"
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" |
Phase of Trial
|
Phase 2 |
Date of First Enrollment (India)
|
02/11/2011 |
Date of Study Completion (India) |
Applicable only for Completed/Terminated trials |
Date of First Enrollment (Global) |
Date Missing |
Date of Study Completion (Global) |
Applicable only for Completed/Terminated trials |
Estimated Duration of Trial
|
Years="2" Months="0" Days="0" |
Recruitment Status of Trial (Global)
|
Not Applicable |
Recruitment Status of Trial (India) |
Open to Recruitment |
Publication Details
|
NIL |
Individual Participant Data (IPD) Sharing Statement
|
Will individual participant data (IPD) be shared publicly (including data dictionaries)?
|
Brief Summary
|
This study is designed as a multicentric open trial in patients with Zof-e-Masana (Overactive Bladder). Patients will receive the study drugs Majoon Flasfa and Majoon Masik ul baul in a dose of 7 gms each once a day. The total duration of treatment will be 12 weeeks. All the laboratory parameters will be recorded at baseline and at the end of the study. Clinical followups will be done at 1st, 4th, 8th and 12th week.
Composition of MAJOON
FALASIFA
1. Maweez Munaqqa 450g
2. Zanjabeel 150g
3. Filfil siyah 150g
4. Filfil Daraz 150g
5. Darchini 150g
6. Amla 150g
7. Post e Balela 150g
8. Sheetraj Hindi 150g
9. Zarawand Madahraj 150g
10. Salab
Misri 150g
11. Maghz
e Chilgoza 150g
12.
Bekh
e Babuna 150g
13.
Maghz
e Narjeel 150g
14. Tukhm
e Babuna 75g
15.
Asal
or Qand e Safaid 7
kg
Composition of MAJOON
MASIKUL BAUL
1. Aqaqia 15g
2. Gulnar Farsi 15g
3. Habb ul Aas 12g
4. Sandal Safaid 10g
5. Sandal Surkh 10g
6. Adas Surkh 10g
7. Charaita Shireen 10g
8. Tukhm e Hummaz 10g
9. Samagh e Arabi 10g
10. Tabasheer 10g
11. Kundur 5g
12.
Julab Q.S
|